<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Glycosylation and related congenital defects" Version="20190213" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Glycosylation is the most common postranslational modification. Defects in this pathway lead to autosomal recessive disorders, called Congenital disorders of glycosylation (CDG). Up to date about 50 CDGs have been identified and more are expected to be discovered. This category of metabolic disorders can be divided into four basic groups depending on where the glycosylation process occurs on the molecule. The depicts pathway depicts the group of N-glycosylation. Generally, N-glycosylation processes spread over three cellular compartments - cytosol, endoplasmic reticulum and Golgi apparatus. The associated mortality rate  in combination with the limited treatment options for CDG, points out the relevance for further investigations of this pathway. Disorders resulting from an enzyme defect are highlighted in pink. This pathway was inspired by Chapter 30 of the book of Blau (ISBN 3642403360 (978-3642403361)).</Comment>
  <BiopaxRef>a0e</BiopaxRef>
  <Graphics BoardWidth="1957.8350611726548" BoardHeight="1307.2717536813923"/>
  <DataNode TextLabel="30.38" GraphId="a3a88" Type="Protein">
    <Comment>Dolichol kinase</Comment>
        </DataNode>
  <DataNode TextLabel="ALG13" GraphId="a56db" Type="Protein">
    <Comment>Labelled in UniProt as Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13.</Comment>
    <Comment>Found manually through RHEA idnetifier. This enzyme was not indicated in the Blau Book, but it catalyzes this exact reaction.</Comment>
        </DataNode>
  <DataNode TextLabel="dolichyl &#10;phosphate" GraphId="ae62c" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="UDP" GraphId="b247e" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="beta-D-glucose" GraphId="b4524" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="DPAGT1" GraphId="cc89b" Type="Protein">
    <Comment>In UniProt described as UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase.</Comment>
    <Comment>Found manually through RHEA identifier reaction. Not indicated in the Blau Book Chapter 30.</Comment>
        </DataNode>
  <DataNode TextLabel="UDP-N-acetyl&#10;alpha-D-glucosamine " GraphId="cfd19" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GlcNAc-PP-Dol" GraphId="e132b" Type="Metabolite">
    <Comment>In RHEA: N-acetyl-&#195;&#381;&#194;&#177;-D-glucosaminyl-diphosphodolichol</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="dolichyl &#10;beta-D-mannosyl &#10;phosphate" GraphId="f390b" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Dolichyl phosphate" GraphId="b31f7" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GMPPB" GraphId="ac4e4" Type="Protein">
    <Comment>AKA mannose-1-phosphate guanylyltransferase [https://en.wikipedia.org/wiki/Mannose-1-phosphate_guanylyltransferase]</Comment>
        </DataNode>
  <DataNode TextLabel="GDP" GraphId="aa7d3" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="30.34" GraphId="badfd" Type="Protein">
    <Comment>AKA B4GALT1; beta-1,4-galactosyltransferase 1</Comment>
        </DataNode>
  <DataNode TextLabel="Man5-GlcNac2-PP-Dol" GraphId="b78b6" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="DPM2" GraphId="b559f" Type="Protein">
    <BiopaxRef>dc2</BiopaxRef>
    <BiopaxRef>cf1</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Man8-GlcNac2-PP-Dol" GraphId="e876d" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man7-GlcNac2-PP-Dol" GraphId="ce77e" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man6-GlcNac2-PP-Dol" GraphId="b8f00" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man9-GlcNac2-PP-Dol" GraphId="be286" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glc3Man9-GlcNac2-PP-Dol" GraphId="ab946" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glc2Man9-GlcNac2-PP-Dol" GraphId="d5524" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GlcMan9-GlcNac2-PP-Dol" GraphId="e7451" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glc2Man9-GlcNac2-Prot" GraphId="d0500" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Glc3Man9-GlcNac2-Prot" GraphId="bdd67" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man3-GlcNac4-Prot" GraphId="ded10" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man3-GlcNac3-Prot" GraphId="f6ec9" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Sia2Gal2Man3-GlcNac4-Prot" GraphId="ed4a0" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Gal2Man3-GlcNac4-Prot" GraphId="c23cb" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="SiaGalMan3-GlcNac3-Prot" GraphId="d5aa3" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="GDP-mannose" GraphId="fe437" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Dol-P-Man" GraphId="fef36" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Mannose 6-Phosphate" GraphId="e3795" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Mannose 1-phosphate" GraphId="efc08" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Fructose 6-phosphate" GraphId="d18f7" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="30.13" GraphId="f21ac" Type="Protein">
    <Comment>AKA MGAT2; N-acetylglucosaminyltransferase 2</Comment>
    <Comment>Function"Plays an essential role in protein N-glycosylation. Catalyzes the transfer of N-acetylglucosamine (GlcNAc) onto the free terminal mannose moiety in the core structure of the nascent N-linked glycan chain, giving rise to the second branch in complex glycans." [https://www.uniprot.org/uniprot/Q10469]</Comment>
        </DataNode>
  <DataNode TextLabel="30.14" GraphId="a818b" Type="Protein">
    <Comment>AKA GCS1; Glucosidase 1</Comment>
    <Comment>Function:"Cleaves the distal alpha 1,2-linked glucose residue from the Glc3Man9GlcNAc2 oligosaccharide precursor in a highly specific manner." [https://www.uniprot.org/uniprot/Q13724]</Comment>
        </DataNode>
  <DataNode TextLabel="30.15" GraphId="c7163" Type="Protein">
    <Comment>AKA TUSC3; oligosaccharyltransferase subunit tusc 3</Comment>
    <BiopaxRef>b1d</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="30.16" GraphId="f0a89" Type="Protein">
    <Comment>Aka MAGT1; magnesium transporter 1</Comment>
        </DataNode>
  <DataNode TextLabel="30.6" GraphId="a08bc" Type="Protein">
    <Comment>AKA ALG8; Glucosyltransferase 2</Comment>
        </DataNode>
  <DataNode TextLabel="30.3" GraphId="b8eec" Type="Protein">
    <Comment>Aka ALG6; glucosyltransferase 1.</Comment>
        </DataNode>
  <DataNode TextLabel="30.10" GraphId="dc495" Type="Protein">
        </DataNode>
  <DataNode TextLabel="30.5" GraphId="ef3ce" Type="Protein">
    <Comment>AKA ALG12, Mannosyltransferase 8</Comment>
        </DataNode>
  <DataNode TextLabel="30.10" GraphId="fc592" Type="Protein">
    <Comment>Aka ;mannosyltransferase 7-9</Comment>
        </DataNode>
  <DataNode TextLabel="30.33" GraphId="dee95" Type="Protein">
    <Comment>AKA MPDU1; Dol-P-Man utilization 1</Comment>
        </DataNode>
  <DataNode TextLabel="30.4" GraphId="a58d7" Type="Protein">
    <Comment>AKA ALG3, mannosyltransferase 6</Comment>
    <Comment>Function:"Adds the first Dol-P-Man derived mannose in an alpha-1,3 linkage to Man5GlcNAc2-PP-Dol" [https://www.uniprot.org/uniprot/Q92685]</Comment>
        </DataNode>
  <DataNode TextLabel="30.2" GraphId="c5f2f" Type="Protein">
    <Comment>AKA MPI, phosphomannose isomerase</Comment>
    <BiopaxRef>bc9</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="30.1" GraphId="d9753" Type="Protein">
    <Comment>AKA PMM, phosphomannomutase 2</Comment>
        </DataNode>
  <DataNode TextLabel="30.31" GraphId="a3955" Type="Protein">
    <Comment>AKA DPM1, GDP-Man:Dol-P mannosyltransferase subunit 1</Comment>
        </DataNode>
  <DataNode TextLabel="30.32" GraphId="ada39" Type="Protein">
    <Comment>AKA DPM3, GDP-Man:Dol-P mannosyltransferase 3</Comment>
    <Comment>"Stabilizer subunit of the dolichol-phosphate mannose (DPM) synthase complex; tethers catalytic subunit DPM1 to the ER" [https://www.uniprot.org/uniprot/Q9P2X0]</Comment>
    <BiopaxRef>cf1</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Man5GIcNAc2-PP-Dol" GraphId="d69b9" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Dolichol phosphate" GraphId="e29cf" Type="Metabolite">
    <Comment>In RHEA stated as dolichyl phosphate, and in this reaction it results in a -2 charge.</Comment>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Dolichol-PP" GraphId="a5f50" Type="Metabolite">
    <Comment>In CheBi known as Dolichol diphosphate</Comment>
    <Graphics Color="0033ff"/>
    </DataNode>
  <DataNode TextLabel="30.39&#10;" GraphId="a7193" Type="Protein">
    <Comment>Known as polyprenol reductase, which catalyzes reduction of the alpha-isoprene subunit of polyprenol. But also known to have steroid dehydrogenase activity.</Comment>
    <BiopaxRef>ebd</BiopaxRef>
    <BiopaxRef>ec3</BiopaxRef>
    <BiopaxRef>eda</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="30.9" GraphId="c9b8f" Type="Protein">
    <Comment>Chitobiosyldiphosphodolichol 
beta-mannosyltransferase mediates the hexosyl group transfer.</Comment>
    <Comment>In Blau Book known as Mannosyltransferase 1</Comment>
        </DataNode>
  <DataNode TextLabel="30.8" GraphId="fc08a" Type="Protein">
    <Comment>Also known as UDP-N-acetylglucosamine-dolichyl-phosphate 
N-acetylglucosaminephosphotransferase, which transfers the hexosyl group</Comment>
        </DataNode>
  <DataNode TextLabel="30.11" GraphId="d8667" Type="Protein">
    <Comment>GDP-Man:Man(3)GlcNAc(2)-PP-
Dol alpha-1,2-mannosyltransferase</Comment>
    <BiopaxRef>fc8</BiopaxRef>
    <BiopaxRef>f2a</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="Man3GIcNAc2-PP-Dol" GraphId="d4df1" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man4GIcNAc2-PP-Dol" GraphId="bccaf" Type="Metabolite">
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Dolichol" GraphId="a606c" Type="Metabolite">
    <Comment>Full name in RHEA: di-trans,poly-cis-dolichol</Comment>
    <BiopaxRef>bf5</BiopaxRef>
    <BiopaxRef>e55</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Polyprenol" GraphId="b3ff0" Type="Metabolite">
    <Comment>In RHEA and UniProt known as di-trans,cis-polyprenol. </Comment>
    <BiopaxRef>a13</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="Man2GIcNAc2PP-Dol" GraphId="aa6c4" Type="Metabolite">
    <Graphics Color="0033ff"/>
    </DataNode>
  <DataNode TextLabel="Mevalonate" GraphId="e6865" Type="Metabolite">
    <BiopaxRef>bab</BiopaxRef>
    <Graphics Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ManGlcNAc2-PP-Dol&#10;" GraphId="fdf5c" Type="Metabolite">
    <Graphics Color="0033ff"/>
    </DataNode>
  <DataNode TextLabel="30.7" GraphId="cc958" Type="Protein">
    <Comment>Alpha-1,3/1,6-
mannosyltransferase ALG2</Comment>
    <BiopaxRef>a99</BiopaxRef>
        </DataNode>
  <DataNode TextLabel="GlcNAc2-PP-Dol" GraphId="ddad1" Type="Metabolite">
    <Comment>Aka N-acetylglucosamine</Comment>
    <Graphics Color="0033ff"/>
    </DataNode>
  <DataNode TextLabel="dolichyl &#10;phosphate" GraphId="c2b35" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="dolichyl &#10;beta-D-mannosyl &#10;phosphate" GraphId="ea48a" Type="Metabolite">
    <Graphics ShapeType="Oval" Color="0000ff"/>
    </DataNode>
  <DataNode TextLabel="ALG14" GraphId="edab9" Type="Protein">
    <Comment Source="OCR">ALG14</Comment>
    <BiopaxRef>d28</BiopaxRef>
        </DataNode>
  <Interaction GraphId="id17ad63cf">
    <Graphics>
      <Point GraphRef="a5f50"/>
      <Point GraphRef="e132b" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="d78e1"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id1f2167e5">
    <Graphics>
      <Point GraphRef="a3a88"/>
      <Point GraphRef="f76f5" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id325af368">
    <Graphics>
      <Point GraphRef="d69b9"/>
      <Point GraphRef="b78b6" ArrowHead="mim-conversion"/>
      <Anchor Position="0.7446290178264462" Shape="None" GraphId="bfc3d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id732b084">
    <Graphics>
      <Point GraphRef="e132b"/>
      <Point GraphRef="ddad1" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="ab3b8"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id7f71fde6">
    <Graphics>
      <Point GraphRef="cfd19"/>
      <Point GraphRef="f5706" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="id8dc9f869">
    <Graphics>
      <Point GraphRef="a56db"/>
      <Point GraphRef="c2b69" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idbf7fa9af">
    <BiopaxRef>e70</BiopaxRef>
    <Graphics>
      <Point GraphRef="cc89b"/>
      <Point GraphRef="d78e1" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="idf58228df">
    <Comment>ALG14 may anchor ALG13 to the ER</Comment>
    <BiopaxRef>c25</BiopaxRef>
    <Graphics>
      <Point GraphRef="edab9"/>
      <Point GraphRef="a56db" ArrowHead="mim-modification"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4e29">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="fef36"/>
      <Point/>
      <Point GraphRef="c4492" ArrowHead="Arrow"/>
      <Anchor Position="0.287848083458371" Shape="None" GraphId="fb767"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a3bc0">
    <Graphics>
      <Point GraphRef="c5f2f"/>
      <Point GraphRef="eb22f" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eeebb">
    <Graphics>
      <Point GraphRef="ada39"/>
      <Point GraphRef="fb767" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d6339">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f6ec9"/>
      <Point GraphRef="d5aa3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ecfe0">
    <Graphics>
      <Point GraphRef="a08bc"/>
      <Point GraphRef="b73ee" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b63a2">
    <BiopaxRef>d29</BiopaxRef>
    <Graphics>
      <Point GraphRef="badfd"/>
      <Point GraphRef="b4b9c" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="acb23">
    <Graphics>
      <Point GraphRef="ac4e4"/>
      <Point GraphRef="c2806" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f0f54">
    <BiopaxRef>f5b</BiopaxRef>
    <Graphics>
      <Point GraphRef="a818b"/>
      <Point GraphRef="ea5f1" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0abd">
    <BiopaxRef>cf1</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b559f"/>
      <Point GraphRef="ada39" ArrowHead="mim-binding"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f747b">
    <BiopaxRef>b63</BiopaxRef>
    <BiopaxRef>d73</BiopaxRef>
    <Graphics>
      <Point GraphRef="c7163"/>
      <Point GraphRef="c2e3c" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fa17e">
    <Graphics>
      <Point GraphRef="b31f7"/>
      <Point GraphRef="d7e6a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ff5a2">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b78b6"/>
      <Point GraphRef="b8f00" ArrowHead="Arrow"/>
      <Anchor Position="0.14261387824605448" Shape="None" GraphId="c4492"/>
      <Anchor Position="0.607900606039389" Shape="None" GraphId="bca0d"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ff285">
    <Graphics>
      <Point GraphRef="fc592"/>
      <Point GraphRef="f9695" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c9982">
    <Graphics>
      <Point GraphRef="d18f7"/>
      <Point GraphRef="e3795" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5605441986186861" Shape="None" GraphId="eb22f"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0a7c">
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="f0a89"/>
      <Point/>
      <Point GraphRef="a707a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cff27">
    <Graphics>
      <Point GraphRef="b8eec"/>
      <Point GraphRef="c5206" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb6bc">
    <Graphics>
      <Point GraphRef="dc495"/>
      <Point GraphRef="c33e2" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a838c">
    <Graphics>
      <Point GraphRef="a3955"/>
      <Point GraphRef="d7e6a" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0453">
    <Graphics>
      <Point GraphRef="a08bc"/>
      <Point GraphRef="a4489" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c974d">
    <BiopaxRef>cf1</BiopaxRef>
    <Graphics ConnectorType="Elbow">
      <Point GraphRef="b559f"/>
      <Point/>
      <Point GraphRef="a3955" ArrowHead="mim-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6846">
    <Graphics>
      <Point GraphRef="ef3ce"/>
      <Point GraphRef="aca47" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e013e">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d0500"/>
      <Point GraphRef="f6ec9" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a44ed">
    <Graphics>
      <Point GraphRef="e3795"/>
      <Point GraphRef="efc08" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5075449078111751" Shape="None" GraphId="f2270"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fa908">
    <Graphics>
      <Point GraphRef="efc08"/>
      <Point GraphRef="fe437" ArrowHead="mim-conversion"/>
      <Anchor Position="0.41152785646957796" Shape="None" GraphId="c2806"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b38f9">
    <Graphics LineStyle="Broken">
      <Point GraphRef="fe437"/>
      <Point GraphRef="fef36" ArrowHead="Arrow"/>
      <Anchor Position="0.6471072127295704" Shape="None" GraphId="d7e6a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0f4b">
    <BiopaxRef>f7c</BiopaxRef>
    <Graphics>
      <Point GraphRef="b8f00"/>
      <Point GraphRef="ce77e" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="f9695"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce68f">
    <Graphics>
      <Point GraphRef="ce77e"/>
      <Point GraphRef="e876d" ArrowHead="mim-conversion"/>
      <Anchor Position="0.2257799044591593" Shape="None" GraphId="aca47"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a3c2a">
    <BiopaxRef>f7c</BiopaxRef>
    <Graphics>
      <Point GraphRef="e876d"/>
      <Point GraphRef="be286" ArrowHead="mim-conversion"/>
      <Anchor Position="0.2984053419036627" Shape="None" GraphId="c33e2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e8e76">
    <Graphics>
      <Point GraphRef="be286"/>
      <Point GraphRef="e7451" ArrowHead="mim-conversion"/>
      <Anchor Position="0.604434072345375" Shape="None" GraphId="c5206"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba20c">
    <Graphics>
      <Point GraphRef="e7451"/>
      <Point GraphRef="d5524" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="a4489"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4a77">
    <Graphics>
      <Point GraphRef="d5524"/>
      <Point GraphRef="ab946" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4744578313252992" Shape="None" GraphId="b73ee"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4f81">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ab946"/>
      <Point GraphRef="bdd67" ArrowHead="Arrow"/>
      <Anchor Position="0.7777463193658052" Shape="None" GraphId="c2e3c"/>
      <Anchor Position="0.37075311438279457" Shape="None" GraphId="a707a"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fd073">
    <Graphics>
      <Point GraphRef="bdd67"/>
      <Point GraphRef="d0500" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="ea5f1"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d7992">
    <BiopaxRef>af2</BiopaxRef>
    <BiopaxRef>b10</BiopaxRef>
    <Graphics>
      <Point GraphRef="f6ec9"/>
      <Point GraphRef="ded10" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4525874465118996" Shape="None" GraphId="f5706"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c966c">
    <Graphics>
      <Point GraphRef="ded10"/>
      <Point GraphRef="c23cb" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3692530313070325" Shape="None" GraphId="b4b9c"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba231">
    <Graphics>
      <Point GraphRef="c23cb"/>
      <Point GraphRef="ed4a0" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8ffe">
    <BiopaxRef>e11</BiopaxRef>
    <Graphics>
      <Point GraphRef="f21ac"/>
      <Point GraphRef="f5706" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef878">
    <Graphics>
      <Point GraphRef="dee95"/>
      <Point GraphRef="bca0d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb494">
    <Graphics>
      <Point GraphRef="a58d7"/>
      <Point GraphRef="bfc3d" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe846">
    <BiopaxRef>de2</BiopaxRef>
    <BiopaxRef>b29</BiopaxRef>
    <BiopaxRef>e6d</BiopaxRef>
    <Graphics>
      <Point GraphRef="d9753"/>
      <Point GraphRef="f2270" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bc3ba">
    <Graphics>
      <Point GraphRef="d7e6a"/>
      <Point GraphRef="aa7d3" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c03e7">
    <Graphics>
      <Point GraphRef="d8667"/>
      <Point GraphRef="b9fe7" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf94d">
    <Graphics>
      <Point GraphRef="e6865"/>
      <Point GraphRef="b3ff0" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ecd8d">
    <Graphics>
      <Point GraphRef="e29cf"/>
      <Point GraphRef="a5f50" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf513">
    <Graphics>
      <Point GraphRef="fdf5c"/>
      <Point GraphRef="aa6c4" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4036881008994179" Shape="None" GraphId="ae754"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bef32">
    <Graphics>
      <Point GraphRef="b3ff0"/>
      <Point GraphRef="a606c" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="cf2ee"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cf254">
    <Graphics>
      <Point GraphRef="cc958"/>
      <Point GraphRef="ae754" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e4c6b">
    <Graphics>
      <Point GraphRef="c9b8f"/>
      <Point GraphRef="a2af4" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f95ef">
    <Graphics>
      <Point GraphRef="aa6c4"/>
      <Point GraphRef="d4df1" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cbb1d">
    <Graphics>
      <Point GraphRef="d8667"/>
      <Point GraphRef="babfc" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cbe91">
    <Graphics>
      <Point GraphRef="a7193"/>
      <Point GraphRef="cf2ee" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce341">
    <Graphics>
      <Point GraphRef="a606c"/>
      <Point GraphRef="e29cf" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="f76f5"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2ae1">
    <Graphics>
      <Point GraphRef="e132b"/>
      <Point GraphRef="ddad1" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6321066769542873" Shape="None" GraphId="c2b69"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bb584">
    <Graphics>
      <Point GraphRef="fc08a"/>
      <Point GraphRef="ab3b8" ArrowHead="mim-catalysis"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f365b">
    <Graphics>
      <Point GraphRef="d4df1"/>
      <Point GraphRef="bccaf" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3844548791824888" Shape="None" GraphId="babfc"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ed165">
    <Graphics>
      <Point GraphRef="ddad1"/>
      <Point GraphRef="fdf5c" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3885902339846319" Shape="None" GraphId="a2af4"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef0fc">
    <Graphics>
      <Point GraphRef="bccaf"/>
      <Point GraphRef="d69b9" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3954987301275068" Shape="None" GraphId="b9fe7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4305">
    <Graphics>
      <Point GraphRef="f390b"/>
      <Point GraphRef="bfc3d" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8999484214894646" Shape="None" GraphId="e4265"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d17ea">
    <Graphics>
      <Point GraphRef="bfc3d"/>
      <Point GraphRef="ae62c" ArrowHead="mim-conversion"/>
      <Anchor Position="0.8999484214894646" Shape="None" GraphId="e6667"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="baa48">
    <Graphics>
      <Point GraphRef="c33e2"/>
      <Point GraphRef="c2b35" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ec94e">
    <Graphics>
      <Point GraphRef="ea48a"/>
      <Point GraphRef="c33e2" ArrowHead="mim-conversion"/>
      <Anchor Position="0.2984053419036627" Shape="None" GraphId="d4503"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9872">
    <Graphics>
      <Point GraphRef="ea5f1"/>
      <Point GraphRef="b4524" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f57d2">
    <Graphics>
      <Point GraphRef="f5706"/>
      <Point GraphRef="b247e" ArrowHead="mim-conversion"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="a2c65">
    <BiopaxRef>e6b</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="fb767"/>
      <Point GraphRef="e7c8f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b3c47">
    <BiopaxRef>d49</BiopaxRef>
    <BiopaxRef>a5b</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="f5706"/>
      <Point GraphRef="ae006" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bcbc8">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="c2e3c"/>
      <Point/>
      <Point GraphRef="faa34" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bf9e8">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="f9695"/>
      <Point/>
      <Point/>
      <Point GraphRef="c0b0f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c9282">
    <BiopaxRef>d60</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="aca47"/>
      <Point GraphRef="fac05" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d4f40">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f2270"/>
      <Point GraphRef="e1a30" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e2054">
    <BiopaxRef>a53</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="c5206"/>
      <Point GraphRef="ee547" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e784f">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d7e6a"/>
      <Point GraphRef="f2deb" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="eabe5">
    <BiopaxRef>e44</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="bca0d"/>
      <Point GraphRef="e9081" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ef7d6">
    <Graphics LineStyle="Broken">
      <Point GraphRef="eb22f"/>
      <Point GraphRef="f4406" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f48e4">
    <BiopaxRef>e9c</BiopaxRef>
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="a707a"/>
      <Point/>
      <Point GraphRef="e4b7d" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f50a5">
    <BiopaxRef>e16</BiopaxRef>
    <Graphics ConnectorType="Elbow" LineStyle="Broken" Color="cc0000">
      <Point GraphRef="f0a89"/>
      <Point GraphRef="e4b7d" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f5908">
    <BiopaxRef>f78</BiopaxRef>
    <BiopaxRef>f8a</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="b73ee"/>
      <Point GraphRef="d1c8e" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fa928">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b4b9c"/>
      <Point GraphRef="d41a8" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fb938">
    <BiopaxRef>f78</BiopaxRef>
    <BiopaxRef>f8a</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="a4489"/>
      <Point GraphRef="d1c8e" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fe7f8">
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="ea5f1"/>
      <Point/>
      <Point GraphRef="e046b" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ff3d1">
    <Graphics LineStyle="Broken">
      <Point GraphRef="a2af4"/>
      <Point GraphRef="a1960" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cd720">
    <Graphics LineStyle="Broken">
      <Point GraphRef="babfc"/>
      <Point GraphRef="a4eda" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d1152">
    <Graphics LineStyle="Broken">
      <Point GraphRef="cf2ee"/>
      <Point GraphRef="a422d" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c6f4a">
    <Graphics LineStyle="Broken">
      <Point GraphRef="f76f5"/>
      <Point GraphRef="cb37d" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f3514">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ae754"/>
      <Point GraphRef="dfc8f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b815c">
    <Graphics LineStyle="Broken">
      <Point GraphRef="b9fe7"/>
      <Point GraphRef="a4eda" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="dcd59">
    <Graphics LineStyle="Broken">
      <Point GraphRef="ab3b8"/>
      <Point GraphRef="d4d85" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="dd9e9">
    <BiopaxRef>f70</BiopaxRef>
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="bfc3d"/>
      <Point GraphRef="eb2ce" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f6156">
    <BiopaxRef>fe1</BiopaxRef>
    <BiopaxRef>d4f</BiopaxRef>
    <Graphics ConnectorType="Elbow" LineStyle="Broken">
      <Point GraphRef="c33e2"/>
      <Point/>
      <Point/>
      <Point GraphRef="c0b0f" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="af2d6">
    <Graphics LineStyle="Broken">
      <Point GraphRef="d78e1"/>
      <Point GraphRef="d4d85" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Pathological role&#10;of MAGT1 related to&#10;mental retardation&#10;is questionable." GraphId="a9e4b">
    <BiopaxRef>e16</BiopaxRef>
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Beta-1,4-galactosyltransferase-&#10;1-deficiency-CDG-IId (CDG-2d)" GraphId="d41a8" Href="https://omim.org/607091">
    <Comment>Short: B4GALT1-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Glucosidase-1-&#10;deficiency- CDG-IIb (CDG-2b)" GraphId="e046b" Href="https://omim.org/606056">
    <Comment>Short: GCS1-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Endoplasmic&#10;Reticulum" GraphId="a2c3c">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Golgi&#10;Apparatus" GraphId="f4da9">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Mannosyltransferase-&#10;1-deficiency-CDG-Ik&#10;" GraphId="a1960" Href="https://omim.org/608540">
    <Comment>Short: ALGl-CDG</Comment>
    <BiopaxRef>b01</BiopaxRef>
    <BiopaxRef>c0b</BiopaxRef>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Mannosyltransferase-&#10;2-deficiency-CDG-Ii" GraphId="dfc8f" Href="https://omim.org/607906">
    <Comment>Short: ALG 2-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Steroid 5 alpha-reductase 2 deficiency" GraphId="a422d" Href="https://omim.org/612379">
    <Comment>Short: SRDSA3-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Mannosyltransferase4-&#10;5-deficiency (ALG11-CDG-Ip)" GraphId="a4eda" Href="https://omim.org/613661">
    <Comment>Short: ALG11-CDG</Comment>
    <BiopaxRef>a99</BiopaxRef>
    <BiopaxRef>fc8</BiopaxRef>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="UDP-GlcNac:Dol-P-GlcNac-&#10;P-transferase deficiency - Ij&#10;" GraphId="d4d85" Href="https://omim.org/608093">
    <Comment>Short: DPAGTl-CDG</Comment>
    <BiopaxRef>fdf</BiopaxRef>
    <BiopaxRef>eed</BiopaxRef>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Dolichol kinase deficiency - CDG - Im" GraphId="cb37d" Href="https://omim.org/610768">
    <Comment>Short: DKl-CDG
</Comment>
    <BiopaxRef>e67</BiopaxRef>
    <BiopaxRef>f2b</BiopaxRef>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Mannosyltransferase6 &#10;deficiency (CDG-Ic)" GraphId="eb2ce" Href="https://omim.org/601110">
    <Comment>Short: ALG3-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Mannosyltransferase 7-9 &#10;deficiency (CDG-II)" GraphId="c0b0f" Href="https://omim.org/608776">
    <Comment>Short: ALG9-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Glucosyltransferase 2&#10;deficiency (CDG-Ih)" GraphId="d1c8e" Href="https://www.omim.org/608104">
    <Comment>Short: ALG 8-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Magnesium transporter 1&#10;deficiency (MAGT1-CDG)" GraphId="e4b7d" Href="https://omim.org/300716">
    <Comment>Short: MAGTI-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="N-acetylglucosaminyltransferase 2&#10;deficiency (CDG-IIa)" GraphId="ae006" Href="https://omim.org/212066">
    <Comment>Short: MGAT2-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Oligosaccharyl-transferase&#10;-subunit-tusc-3-deficiency " GraphId="faa34" Href="https://omim.org/611093">
    <Comment>Also known as MRT7, autosomal recessive mental retardation disorder</Comment>
    <Comment>Short: TiJSC3-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Glucosyltransferase-1-&#10;deficiency-CDG-Ic (CDG1c)" GraphId="ee547" Href="https://omim.org/603147">
    <Comment>Short: ALG6-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Mannosyltransferase-8-&#10;deficiency-CDG-Ig (CDG-1g)" GraphId="fac05" Href="https://omim.org/607143">
    <Comment>Short: ALG 12-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Dol-P-Man utilization &#10;1 deficiency (CDG-1f)" GraphId="e9081" Href="https://omim.org/609180">
    <Comment>Short: MPDU1-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="GDP-Man:Dol-Pmannosyl-&#10;transferase-3 -deficiency" GraphId="e7c8f" Href="https://omim.org/612937">
    <Comment>Short: DPM3-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="GDP-Man:Dol-P mannosyltransferase &#10;subunit 1 deficiency-CDG Ie (CDG-1e)" GraphId="f2deb" Href="https://omim.org/608799">
    <Comment>Short: DPM1-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Phosphomannomutase-2-&#10;deficiency- CDG-Ia (CDG-1a)" GraphId="e1a30" Href="https://omim.org/212065">
    <Comment>The OMIM identifer indicated in teh Blau Book (main reference) doe snot coincide with the disease but the gene/protein. Therefore the OMIM link was adjusted accordingly. </Comment>
    <Comment>Short: PMM2-CDG</Comment>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Label TextLabel="Phosphomannose-isomerase-&#10;deficiency- CDG-Ib (CDG-1b)" GraphId="f4406" Href="https://omim.org/602579">
    <Comment>Short: MPI-CDG</Comment>
    <BiopaxRef>d21</BiopaxRef>
    <Graphics FillColor="ffccff" FontStyle="Italic" ShapeType="RoundedRectangle" Color="0000ff"/>
  </Label>
  <Shape GraphId="be843">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="ca286">
    <Graphics ShapeType="Golgi Apparatus" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="c8e62">
    <Graphics ShapeType="RoundedRectangle" Color="c0c0c0"/>
  </Shape>
  <Shape GraphId="c49a9">
    <Graphics ShapeType="Endoplasmic Reticulum" Color="c0c0c0"/>
  </Shape>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f7c">
      <bp:ID >15987956</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >ALG9 mannosyltransferase is involved in two different steps of lipid-linked oligosaccharide biosynthesis.</bp:TITLE>
      <bp:SOURCE >Glycobiology</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Frank CG</bp:AUTHORS>
      <bp:AUTHORS >Aebi M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c0b">
      <bp:ID >14973782</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >14973782</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Congenital disorder of glycosylationtype Ik (CDG-Ik): a defect of mannosyltransferase I.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Kranz C</bp:AUTHORS>
      <bp:AUTHORS >Denecke J</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >Sohlbach K</bp:AUTHORS>
      <bp:AUTHORS >Jeske S</bp:AUTHORS>
      <bp:AUTHORS >Meinhardt F</bp:AUTHORS>
      <bp:AUTHORS >Rossi R</bp:AUTHORS>
      <bp:AUTHORS >Gudowius S</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b1d">
      <bp:ID >18452889</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A defect in the TUSC3 gene is associated with autosomal recessive mental retardation.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Garshasbi M</bp:AUTHORS>
      <bp:AUTHORS >Hadavi V</bp:AUTHORS>
      <bp:AUTHORS >Habibi H</bp:AUTHORS>
      <bp:AUTHORS >Kahrizi K</bp:AUTHORS>
      <bp:AUTHORS >Kariminejad R</bp:AUTHORS>
      <bp:AUTHORS >Behjati F</bp:AUTHORS>
      <bp:AUTHORS >Tzschach A</bp:AUTHORS>
      <bp:AUTHORS >Najmabadi H</bp:AUTHORS>
      <bp:AUTHORS >Ropers HH</bp:AUTHORS>
      <bp:AUTHORS >Kuss AW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de2">
      <bp:ID >11058895</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).</bp:TITLE>
      <bp:SOURCE >Hum Mutat</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Matthijs G</bp:AUTHORS>
      <bp:AUTHORS >Schollen E</bp:AUTHORS>
      <bp:AUTHORS >Bjursell C</bp:AUTHORS>
      <bp:AUTHORS >Erlandson A</bp:AUTHORS>
      <bp:AUTHORS >Freeze H</bp:AUTHORS>
      <bp:AUTHORS >Imtiaz F</bp:AUTHORS>
      <bp:AUTHORS >Kjaergaard S</bp:AUTHORS>
      <bp:AUTHORS >Martinsson T</bp:AUTHORS>
      <bp:AUTHORS >Schwartz M</bp:AUTHORS>
      <bp:AUTHORS >Seta N</bp:AUTHORS>
      <bp:AUTHORS >Vuillaumier-Barrot S</bp:AUTHORS>
      <bp:AUTHORS >Westphal V</bp:AUTHORS>
      <bp:AUTHORS >Winchester B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f78">
      <bp:ID >12480927</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Chantret I</bp:AUTHORS>
      <bp:AUTHORS >Dancourt J</bp:AUTHORS>
      <bp:AUTHORS >Dupr&#233; T</bp:AUTHORS>
      <bp:AUTHORS >Delenda C</bp:AUTHORS>
      <bp:AUTHORS >Bucher S</bp:AUTHORS>
      <bp:AUTHORS >Vuillaumier-Barrot S</bp:AUTHORS>
      <bp:AUTHORS >Ogier de Baulny H</bp:AUTHORS>
      <bp:AUTHORS >Peletan C</bp:AUTHORS>
      <bp:AUTHORS >Danos O</bp:AUTHORS>
      <bp:AUTHORS >Seta N</bp:AUTHORS>
      <bp:AUTHORS >Durand G</bp:AUTHORS>
      <bp:AUTHORS >Oriol R</bp:AUTHORS>
      <bp:AUTHORS >Codogno P</bp:AUTHORS>
      <bp:AUTHORS >Moore SE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b29">
      <bp:ID >10527672</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).</bp:TITLE>
      <bp:SOURCE >Mol Genet Metab</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Matthijs G</bp:AUTHORS>
      <bp:AUTHORS >Schollen E</bp:AUTHORS>
      <bp:AUTHORS >Heykants L</bp:AUTHORS>
      <bp:AUTHORS >Gr&#252;newald S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c25">
      <bp:ID >16100110</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine transferase required for the second step of N-linked glycosylation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Gao XD</bp:AUTHORS>
      <bp:AUTHORS >Tachikawa H</bp:AUTHORS>
      <bp:AUTHORS >Sato T</bp:AUTHORS>
      <bp:AUTHORS >Jigami Y</bp:AUTHORS>
      <bp:AUTHORS >Dean N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bab">
      <bp:ID >5288798</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pitfalls in early diagnosis of oral epidermoid carcinoma.</bp:TITLE>
      <bp:SOURCE >J Can Dent Assoc (Tor)</bp:SOURCE>
      <bp:YEAR >1970</bp:YEAR>
      <bp:AUTHORS >Dick HM</bp:AUTHORS>
      <bp:AUTHORS >Strelioff MG</bp:AUTHORS>
      <bp:AUTHORS >McMurchy KA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >congenital disorder of glycosylation</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:5212</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d28">
      <bp:ID >29874875</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.</bp:TITLE>
      <bp:SOURCE >Int J Mol Sci</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Rodr&#195;&#402;&#194;&#173;guez Cruz PM</bp:AUTHORS>
      <bp:AUTHORS >Palace J</bp:AUTHORS>
      <bp:AUTHORS >Beeson D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >inherited metabolic disorder</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:655</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d21">
      <bp:ID >9525984</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Niehues R</bp:AUTHORS>
      <bp:AUTHORS >Hasilik M</bp:AUTHORS>
      <bp:AUTHORS >Alton G</bp:AUTHORS>
      <bp:AUTHORS >K&#246;rner C</bp:AUTHORS>
      <bp:AUTHORS >Schiebe-Sukumar M</bp:AUTHORS>
      <bp:AUTHORS >Koch HG</bp:AUTHORS>
      <bp:AUTHORS >Zimmer KP</bp:AUTHORS>
      <bp:AUTHORS >Wu R</bp:AUTHORS>
      <bp:AUTHORS >Harms E</bp:AUTHORS>
      <bp:AUTHORS >Reiter K</bp:AUTHORS>
      <bp:AUTHORS >von Figura K</bp:AUTHORS>
      <bp:AUTHORS >Freeze HH</bp:AUTHORS>
      <bp:AUTHORS >Harms HK</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d49">
      <bp:ID >8808595</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Tan J</bp:AUTHORS>
      <bp:AUTHORS >Dunn J</bp:AUTHORS>
      <bp:AUTHORS >Jaeken J</bp:AUTHORS>
      <bp:AUTHORS >Schachter H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e44">
      <bp:ID >11733556</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If).</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Kranz C</bp:AUTHORS>
      <bp:AUTHORS >Denecke J</bp:AUTHORS>
      <bp:AUTHORS >Lehrman MA</bp:AUTHORS>
      <bp:AUTHORS >Ray S</bp:AUTHORS>
      <bp:AUTHORS >Kienz P</bp:AUTHORS>
      <bp:AUTHORS >Kreissel G</bp:AUTHORS>
      <bp:AUTHORS >Sagi D</bp:AUTHORS>
      <bp:AUTHORS >Peter-Katalinic J</bp:AUTHORS>
      <bp:AUTHORS >Freeze HH</bp:AUTHORS>
      <bp:AUTHORS >Schmid T</bp:AUTHORS>
      <bp:AUTHORS >Jackowski-Dohrmann S</bp:AUTHORS>
      <bp:AUTHORS >Harms E</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf1">
      <bp:ID >10835346</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >10835346</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Maeda Y</bp:AUTHORS>
      <bp:AUTHORS >Tanaka S</bp:AUTHORS>
      <bp:AUTHORS >Hino J</bp:AUTHORS>
      <bp:AUTHORS >Kangawa K</bp:AUTHORS>
      <bp:AUTHORS >Kinoshita T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f70">
      <bp:ID >10581255</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >K&#246;rner C</bp:AUTHORS>
      <bp:AUTHORS >Knauer R</bp:AUTHORS>
      <bp:AUTHORS >Stephani U</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >von Figura K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebd">
      <bp:ID >20637498</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder.</bp:TITLE>
      <bp:SOURCE >Cell</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Cantagrel V</bp:AUTHORS>
      <bp:AUTHORS >Lefeber DJ</bp:AUTHORS>
      <bp:AUTHORS >Ng BG</bp:AUTHORS>
      <bp:AUTHORS >Guan Z</bp:AUTHORS>
      <bp:AUTHORS >Silhavy JL</bp:AUTHORS>
      <bp:AUTHORS >Bielas SL</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >Hombauer H</bp:AUTHORS>
      <bp:AUTHORS >Adamowicz M</bp:AUTHORS>
      <bp:AUTHORS >Swiezewska E</bp:AUTHORS>
      <bp:AUTHORS >De Brouwer AP</bp:AUTHORS>
      <bp:AUTHORS >Bl&#252;mel P</bp:AUTHORS>
      <bp:AUTHORS >Sykut-Cegielska J</bp:AUTHORS>
      <bp:AUTHORS >Houliston S</bp:AUTHORS>
      <bp:AUTHORS >Swistun D</bp:AUTHORS>
      <bp:AUTHORS >Ali BR</bp:AUTHORS>
      <bp:AUTHORS >Dobyns WB</bp:AUTHORS>
      <bp:AUTHORS >Babovic-Vuksanovic D</bp:AUTHORS>
      <bp:AUTHORS >van Bokhoven H</bp:AUTHORS>
      <bp:AUTHORS >Wevers RA</bp:AUTHORS>
      <bp:AUTHORS >Raetz CR</bp:AUTHORS>
      <bp:AUTHORS >Freeze HH</bp:AUTHORS>
      <bp:AUTHORS >Morava E</bp:AUTHORS>
      <bp:AUTHORS >Al-Gazali L</bp:AUTHORS>
      <bp:AUTHORS >Gleeson JG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a5b">
      <bp:ID >11228641</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facialdysmorphism.</bp:TITLE>
      <bp:SOURCE >J Med Genet</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Cormier-Daire V</bp:AUTHORS>
      <bp:AUTHORS >Amiel J</bp:AUTHORS>
      <bp:AUTHORS >Vuillaumier-Barrot S</bp:AUTHORS>
      <bp:AUTHORS >Tan J</bp:AUTHORS>
      <bp:AUTHORS >Durand G</bp:AUTHORS>
      <bp:AUTHORS >Munnich A</bp:AUTHORS>
      <bp:AUTHORS >Le Merrer M</bp:AUTHORS>
      <bp:AUTHORS >Seta N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9c">
      <bp:ID >18455129</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Molinari F</bp:AUTHORS>
      <bp:AUTHORS >Foulquier F</bp:AUTHORS>
      <bp:AUTHORS >Tarpey PS</bp:AUTHORS>
      <bp:AUTHORS >Morelle W</bp:AUTHORS>
      <bp:AUTHORS >Boissel S</bp:AUTHORS>
      <bp:AUTHORS >Teague J</bp:AUTHORS>
      <bp:AUTHORS >Edkins S</bp:AUTHORS>
      <bp:AUTHORS >Futreal PA</bp:AUTHORS>
      <bp:AUTHORS >Stratton MR</bp:AUTHORS>
      <bp:AUTHORS >Turner G</bp:AUTHORS>
      <bp:AUTHORS >Matthijs G</bp:AUTHORS>
      <bp:AUTHORS >Gecz J</bp:AUTHORS>
      <bp:AUTHORS >Munnich A</bp:AUTHORS>
      <bp:AUTHORS >Colleaux L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a99">
      <bp:ID >12684507</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >12684507</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Thiel C</bp:AUTHORS>
      <bp:AUTHORS >Schwarz M</bp:AUTHORS>
      <bp:AUTHORS >Peng J</bp:AUTHORS>
      <bp:AUTHORS >Grzmil M</bp:AUTHORS>
      <bp:AUTHORS >Hasilik M</bp:AUTHORS>
      <bp:AUTHORS >Braulke T</bp:AUTHORS>
      <bp:AUTHORS >Kohlsch&#252;tter A</bp:AUTHORS>
      <bp:AUTHORS >von Figura K</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >K&#246;rner C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eda">
      <bp:ID >10898110</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.</bp:TITLE>
      <bp:SOURCE >Pharmacogenetics</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Makridakis NM</bp:AUTHORS>
      <bp:AUTHORS >di Salle E</bp:AUTHORS>
      <bp:AUTHORS >Reichardt JK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminic acid dissimilation pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000224</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0e">
      <bp:ID >9783642403361</bp:ID>
      <bp:DB >ISBN</bp:DB>
      <bp:TITLE >Physician's Guide to the Diagnosis, Treatment, and Follow-Up of inherited Metabolic Diseases</bp:TITLE>
      <bp:SOURCE >ISBN 978-3-642400337-8</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Blau</bp:AUTHORS>
      <bp:AUTHORS >Nenad</bp:AUTHORS>
      <bp:AUTHORS >Duran</bp:AUTHORS>
      <bp:AUTHORS >Marinus</bp:AUTHORS>
      <bp:AUTHORS >Gibson, K</bp:AUTHORS>
      <bp:AUTHORS >Micheal</bp:AUTHORS>
      <bp:AUTHORS >Dionsi-Vici</bp:AUTHORS>
      <bp:AUTHORS >Carlo</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e67">
      <bp:ID >17273964</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Kranz C</bp:AUTHORS>
      <bp:AUTHORS >Jungeblut C</bp:AUTHORS>
      <bp:AUTHORS >Denecke J</bp:AUTHORS>
      <bp:AUTHORS >Erlekotte A</bp:AUTHORS>
      <bp:AUTHORS >Sohlbach C</bp:AUTHORS>
      <bp:AUTHORS >Debus V</bp:AUTHORS>
      <bp:AUTHORS >Kehl HG</bp:AUTHORS>
      <bp:AUTHORS >Harms E</bp:AUTHORS>
      <bp:AUTHORS >Reith A</bp:AUTHORS>
      <bp:AUTHORS >Reichel S</bp:AUTHORS>
      <bp:AUTHORS >Grobe H</bp:AUTHORS>
      <bp:AUTHORS >Hammersen G</bp:AUTHORS>
      <bp:AUTHORS >Schwarzer U</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdf">
      <bp:ID >22304930</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.</bp:TITLE>
      <bp:SOURCE >Mol Genet Metab</bp:SOURCE>
      <bp:YEAR >2012</bp:YEAR>
      <bp:AUTHORS >W&#252;rde AE</bp:AUTHORS>
      <bp:AUTHORS >Reunert J</bp:AUTHORS>
      <bp:AUTHORS >Rust S</bp:AUTHORS>
      <bp:AUTHORS >Hertzberg C</bp:AUTHORS>
      <bp:AUTHORS >Haverk&#228;mper S</bp:AUTHORS>
      <bp:AUTHORS >N&#252;rnberg G</bp:AUTHORS>
      <bp:AUTHORS >N&#252;rnberg P</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >Rossi R</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e11">
      <bp:ID >29666272</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Human&lt;i&gt;N&lt;/i&gt;-acetylglucosaminyltransferase II substrate recognition uses a modular architecture that includes a convergent exosite.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Kadirvelraj R</bp:AUTHORS>
      <bp:AUTHORS >Yang JY</bp:AUTHORS>
      <bp:AUTHORS >Sanders JH</bp:AUTHORS>
      <bp:AUTHORS >Liu L</bp:AUTHORS>
      <bp:AUTHORS >Ramiah A</bp:AUTHORS>
      <bp:AUTHORS >Prabhakar PK</bp:AUTHORS>
      <bp:AUTHORS >Boons GJ</bp:AUTHORS>
      <bp:AUTHORS >Wood ZA</bp:AUTHORS>
      <bp:AUTHORS >Moremen KW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eed">
      <bp:ID >12872255</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) causes a novel congenital disorder of Glycosylation Type Ij.</bp:TITLE>
      <bp:SOURCE >Hum Mutat</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Wu X</bp:AUTHORS>
      <bp:AUTHORS >Rush JS</bp:AUTHORS>
      <bp:AUTHORS >Karaoglu D</bp:AUTHORS>
      <bp:AUTHORS >Krasnewich D</bp:AUTHORS>
      <bp:AUTHORS >Lubinsky MS</bp:AUTHORS>
      <bp:AUTHORS >Waechter CJ</bp:AUTHORS>
      <bp:AUTHORS >Gilmore R</bp:AUTHORS>
      <bp:AUTHORS >Freeze HH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b10">
      <bp:ID >7635144</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2- N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Tan J</bp:AUTHORS>
      <bp:AUTHORS >D'Agostaro AF</bp:AUTHORS>
      <bp:AUTHORS >Bendiak B</bp:AUTHORS>
      <bp:AUTHORS >Reck F</bp:AUTHORS>
      <bp:AUTHORS >Sarkar M</bp:AUTHORS>
      <bp:AUTHORS >Squire JA</bp:AUTHORS>
      <bp:AUTHORS >Leong P</bp:AUTHORS>
      <bp:AUTHORS >Schachter H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2a">
      <bp:ID >16878994</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >In vitro evidence for the dual function of Alg2 and Alg11: essential mannosyltransferases in N-linked glycoprotein biosynthesis.</bp:TITLE>
      <bp:SOURCE >Biochemistry</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >O'Reilly MK</bp:AUTHORS>
      <bp:AUTHORS >Zhang G</bp:AUTHORS>
      <bp:AUTHORS >Imperiali B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d29">
      <bp:ID >11901181</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Hansske B</bp:AUTHORS>
      <bp:AUTHORS >Thiel C</bp:AUTHORS>
      <bp:AUTHORS >L&#252;bke T</bp:AUTHORS>
      <bp:AUTHORS >Hasilik M</bp:AUTHORS>
      <bp:AUTHORS >H&#246;ning S</bp:AUTHORS>
      <bp:AUTHORS >Peters V</bp:AUTHORS>
      <bp:AUTHORS >Heidemann PH</bp:AUTHORS>
      <bp:AUTHORS >Hoffmann GF</bp:AUTHORS>
      <bp:AUTHORS >Berger EG</bp:AUTHORS>
      <bp:AUTHORS >von Figura K</bp:AUTHORS>
      <bp:AUTHORS >K&#246;rner C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >autosomal recessive disease</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >DOID:0050737</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5b">
      <bp:ID >10788335</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >De Praeter CM</bp:AUTHORS>
      <bp:AUTHORS >Gerwig GJ</bp:AUTHORS>
      <bp:AUTHORS >Bause E</bp:AUTHORS>
      <bp:AUTHORS >Nuytinck LK</bp:AUTHORS>
      <bp:AUTHORS >Vliegenthart JF</bp:AUTHORS>
      <bp:AUTHORS >Breuer W</bp:AUTHORS>
      <bp:AUTHORS >Kamerling JP</bp:AUTHORS>
      <bp:AUTHORS >Espeel MF</bp:AUTHORS>
      <bp:AUTHORS >Martin JJ</bp:AUTHORS>
      <bp:AUTHORS >De Paepe AM</bp:AUTHORS>
      <bp:AUTHORS >Chan NW</bp:AUTHORS>
      <bp:AUTHORS >Dacremont GA</bp:AUTHORS>
      <bp:AUTHORS >Van Coster RN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dc2">
      <bp:ID >10944123</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-P and is regulated by DPM2.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Watanabe R</bp:AUTHORS>
      <bp:AUTHORS >Murakami Y</bp:AUTHORS>
      <bp:AUTHORS >Marmor MD</bp:AUTHORS>
      <bp:AUTHORS >Inoue N</bp:AUTHORS>
      <bp:AUTHORS >Maeda Y</bp:AUTHORS>
      <bp:AUTHORS >Hino J</bp:AUTHORS>
      <bp:AUTHORS >Kangawa K</bp:AUTHORS>
      <bp:AUTHORS >Julius M</bp:AUTHORS>
      <bp:AUTHORS >Kinoshita T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d73">
      <bp:ID >12887896</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties.</bp:TITLE>
      <bp:SOURCE >Mol Cell</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Kelleher DJ</bp:AUTHORS>
      <bp:AUTHORS >Karaoglu D</bp:AUTHORS>
      <bp:AUTHORS >Mandon EC</bp:AUTHORS>
      <bp:AUTHORS >Gilmore R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af2">
      <bp:ID >6366476</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glycosyltransferases involved in elongation of N-glycosidically linked oligosaccharides of the complex or N-acetyllactosamine type.</bp:TITLE>
      <bp:SOURCE >Methods Enzymol</bp:SOURCE>
      <bp:YEAR >1983</bp:YEAR>
      <bp:AUTHORS >Schachter H</bp:AUTHORS>
      <bp:AUTHORS >Narasimhan S</bp:AUTHORS>
      <bp:AUTHORS >Gleeson P</bp:AUTHORS>
      <bp:AUTHORS >Vella G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e55">
      <bp:ID >25270028</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genetic defects in dolichol metabolism.</bp:TITLE>
      <bp:SOURCE >J Inherit Metab Dis</bp:SOURCE>
      <bp:YEAR >2015</bp:YEAR>
      <bp:AUTHORS >Buczkowska A</bp:AUTHORS>
      <bp:AUTHORS >Swiezewska E</bp:AUTHORS>
      <bp:AUTHORS >Lefeber DJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e70">
      <bp:ID >29459785</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.</bp:TITLE>
      <bp:SOURCE >Nat Struct Mol Biol</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Yoo J</bp:AUTHORS>
      <bp:AUTHORS >Mashalidis EH</bp:AUTHORS>
      <bp:AUTHORS >Kuk ACY</bp:AUTHORS>
      <bp:AUTHORS >Yamamoto K</bp:AUTHORS>
      <bp:AUTHORS >Kaeser B</bp:AUTHORS>
      <bp:AUTHORS >Ichikawa S</bp:AUTHORS>
      <bp:AUTHORS >Lee SY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc8">
      <bp:ID >20080937</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip.</bp:TITLE>
      <bp:SOURCE >Hum Mol Genet</bp:SOURCE>
      <bp:YEAR >2010</bp:YEAR>
      <bp:AUTHORS >Rind N</bp:AUTHORS>
      <bp:AUTHORS >Schmeiser V</bp:AUTHORS>
      <bp:AUTHORS >Thiel C</bp:AUTHORS>
      <bp:AUTHORS >Absmanner B</bp:AUTHORS>
      <bp:AUTHORS >L&#252;bbehusen J</bp:AUTHORS>
      <bp:AUTHORS >Hocks J</bp:AUTHORS>
      <bp:AUTHORS >Apeshiotis N</bp:AUTHORS>
      <bp:AUTHORS >Wilichowski E</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >K&#246;rner C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f2b">
      <bp:ID >28816422</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dolichol kinase deficiency (DOLK-CDG): Two new cases and expansion of phenotype.</bp:TITLE>
      <bp:SOURCE >Am J Med Genet A</bp:SOURCE>
      <bp:YEAR >2017</bp:YEAR>
      <bp:AUTHORS >Rush ET</bp:AUTHORS>
      <bp:AUTHORS >Baker CV</bp:AUTHORS>
      <bp:AUTHORS >Rizzo WB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a13">
      <bp:ID >29297247</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The history and recent advances in research of polyprenol and its derivatives.</bp:TITLE>
      <bp:SOURCE >Biosci Biotechnol Biochem</bp:SOURCE>
      <bp:YEAR >2018</bp:YEAR>
      <bp:AUTHORS >Sagami H</bp:AUTHORS>
      <bp:AUTHORS >Swiezewska E</bp:AUTHORS>
      <bp:AUTHORS >Shidoji Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b63">
      <bp:ID >24685145</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Structural basis of substrate specificity of human oligosaccharyl transferase subunit N33/Tusc3 and its role in regulating protein N-glycosylation.</bp:TITLE>
      <bp:SOURCE >Structure</bp:SOURCE>
      <bp:YEAR >2014</bp:YEAR>
      <bp:AUTHORS >Mohorko E</bp:AUTHORS>
      <bp:AUTHORS >Owen RL</bp:AUTHORS>
      <bp:AUTHORS >Maloj&#269;i&#263; G</bp:AUTHORS>
      <bp:AUTHORS >Brozzo MS</bp:AUTHORS>
      <bp:AUTHORS >Aebi M</bp:AUTHORS>
      <bp:AUTHORS >Glockshuber R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6d">
      <bp:ID >17166182</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.</bp:TITLE>
      <bp:SOURCE >Ann Hum Genet</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Quelhas D</bp:AUTHORS>
      <bp:AUTHORS >Quental R</bp:AUTHORS>
      <bp:AUTHORS >Vilarinho L</bp:AUTHORS>
      <bp:AUTHORS >Amorim A</bp:AUTHORS>
      <bp:AUTHORS >Azevedo L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a53">
      <bp:ID >21334936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic).</bp:TITLE>
      <bp:SOURCE >Mol Genet Metab</bp:SOURCE>
      <bp:YEAR >2011</bp:YEAR>
      <bp:AUTHORS >Miller BS</bp:AUTHORS>
      <bp:AUTHORS >Freeze HH</bp:AUTHORS>
      <bp:AUTHORS >Hoffmann GF</bp:AUTHORS>
      <bp:AUTHORS >Sarafoglou K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6b">
      <bp:ID >19576565</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Lefeber DJ</bp:AUTHORS>
      <bp:AUTHORS >Sch&#246;nberger J</bp:AUTHORS>
      <bp:AUTHORS >Morava E</bp:AUTHORS>
      <bp:AUTHORS >Guillard M</bp:AUTHORS>
      <bp:AUTHORS >Huyben KM</bp:AUTHORS>
      <bp:AUTHORS >Verrijp K</bp:AUTHORS>
      <bp:AUTHORS >Grafakou O</bp:AUTHORS>
      <bp:AUTHORS >Evangeliou A</bp:AUTHORS>
      <bp:AUTHORS >Preijers FW</bp:AUTHORS>
      <bp:AUTHORS >Manta P</bp:AUTHORS>
      <bp:AUTHORS >Yildiz J</bp:AUTHORS>
      <bp:AUTHORS >Gr&#252;newald S</bp:AUTHORS>
      <bp:AUTHORS >Spilioti M</bp:AUTHORS>
      <bp:AUTHORS >van den Elzen C</bp:AUTHORS>
      <bp:AUTHORS >Klein D</bp:AUTHORS>
      <bp:AUTHORS >Hess D</bp:AUTHORS>
      <bp:AUTHORS >Ashida H</bp:AUTHORS>
      <bp:AUTHORS >Hofsteenge J</bp:AUTHORS>
      <bp:AUTHORS >Maeda Y</bp:AUTHORS>
      <bp:AUTHORS >van den Heuvel L</bp:AUTHORS>
      <bp:AUTHORS >Lammens M</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >Wevers RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe1">
      <bp:ID >15148656</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >15148656</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Frank CG</bp:AUTHORS>
      <bp:AUTHORS >Grubenmann CE</bp:AUTHORS>
      <bp:AUTHORS >Eyaid W</bp:AUTHORS>
      <bp:AUTHORS >Berger EG</bp:AUTHORS>
      <bp:AUTHORS >Aebi M</bp:AUTHORS>
      <bp:AUTHORS >Hennet T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d4f">
      <bp:ID >15945070</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features.</bp:TITLE>
      <bp:SOURCE >Am J Med Genet A</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Weinstein M</bp:AUTHORS>
      <bp:AUTHORS >Schollen E</bp:AUTHORS>
      <bp:AUTHORS >Matthijs G</bp:AUTHORS>
      <bp:AUTHORS >Neupert C</bp:AUTHORS>
      <bp:AUTHORS >Hennet T</bp:AUTHORS>
      <bp:AUTHORS >Grubenmann CE</bp:AUTHORS>
      <bp:AUTHORS >Frank CG</bp:AUTHORS>
      <bp:AUTHORS >Aebi M</bp:AUTHORS>
      <bp:AUTHORS >Clarke JT</bp:AUTHORS>
      <bp:AUTHORS >Griffiths A</bp:AUTHORS>
      <bp:AUTHORS >Seargeant L</bp:AUTHORS>
      <bp:AUTHORS >Poplawski N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec3">
      <bp:ID >17986282</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer.</bp:TITLE>
      <bp:SOURCE >Cancer Sci</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Uemura M</bp:AUTHORS>
      <bp:AUTHORS >Tamura K</bp:AUTHORS>
      <bp:AUTHORS >Chung S</bp:AUTHORS>
      <bp:AUTHORS >Honma S</bp:AUTHORS>
      <bp:AUTHORS >Okuyama A</bp:AUTHORS>
      <bp:AUTHORS >Nakamura Y</bp:AUTHORS>
      <bp:AUTHORS >Nakagawa H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >altered carbohydrate metabolic pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000305</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e16">
      <bp:ID >23871722</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2013</bp:YEAR>
      <bp:AUTHORS >Piton A</bp:AUTHORS>
      <bp:AUTHORS >Redin C</bp:AUTHORS>
      <bp:AUTHORS >Mandel JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8a">
      <bp:ID >8016100</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >New phenotype of mutations deficient in glucosylation of the lipid-linked oligosaccharide: cloning of the ALG8 locus.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1994</bp:YEAR>
      <bp:AUTHORS >Stagljar I</bp:AUTHORS>
      <bp:AUTHORS >te Heesen S</bp:AUTHORS>
      <bp:AUTHORS >Aebi M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc9">
      <bp:ID >10980531</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib).</bp:TITLE>
      <bp:SOURCE >Hum Mutat</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Schollen E</bp:AUTHORS>
      <bp:AUTHORS >Dorland L</bp:AUTHORS>
      <bp:AUTHORS >de Koning TJ</bp:AUTHORS>
      <bp:AUTHORS >Van Diggelen OP</bp:AUTHORS>
      <bp:AUTHORS >Huijmans JG</bp:AUTHORS>
      <bp:AUTHORS >Marquardt T</bp:AUTHORS>
      <bp:AUTHORS >Babovic-Vuksanovic D</bp:AUTHORS>
      <bp:AUTHORS >Patterson M</bp:AUTHORS>
      <bp:AUTHORS >Imtiaz F</bp:AUTHORS>
      <bp:AUTHORS >Winchester B</bp:AUTHORS>
      <bp:AUTHORS >Adamowicz M</bp:AUTHORS>
      <bp:AUTHORS >Pronicka E</bp:AUTHORS>
      <bp:AUTHORS >Freeze H</bp:AUTHORS>
      <bp:AUTHORS >Matthijs G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf5">
      <bp:ID >15741281</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Accumulation of dolichol in older tissues satisfies the proposed criteria to be qualified a biomarker of aging.</bp:TITLE>
      <bp:SOURCE >J Gerontol A Biol Sci Med Sci</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Parentini I</bp:AUTHORS>
      <bp:AUTHORS >Cavallini G</bp:AUTHORS>
      <bp:AUTHORS >Donati A</bp:AUTHORS>
      <bp:AUTHORS >Gori Z</bp:AUTHORS>
      <bp:AUTHORS >Bergamini E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d60">
      <bp:ID >12217961</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg.</bp:TITLE>
      <bp:SOURCE >Hum Mol Genet</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Grubenmann CE</bp:AUTHORS>
      <bp:AUTHORS >Frank CG</bp:AUTHORS>
      <bp:AUTHORS >Kjaergaard S</bp:AUTHORS>
      <bp:AUTHORS >Berger EG</bp:AUTHORS>
      <bp:AUTHORS >Aebi M</bp:AUTHORS>
      <bp:AUTHORS >Hennet T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b01">
      <bp:ID >14973778</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik.</bp:TITLE>
      <bp:SOURCE >Am J Hum Genet</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Schwarz M</bp:AUTHORS>
      <bp:AUTHORS >Thiel C</bp:AUTHORS>
      <bp:AUTHORS >L&#252;bbehusen J</bp:AUTHORS>
      <bp:AUTHORS >Dorland B</bp:AUTHORS>
      <bp:AUTHORS >de Koning T</bp:AUTHORS>
      <bp:AUTHORS >von Figura K</bp:AUTHORS>
      <bp:AUTHORS >Lehle L</bp:AUTHORS>
      <bp:AUTHORS >K&#246;rner C</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>disease pathway</bp:TERM><bp:ID>PW:0000013</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>